JP2019521078A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521078A5
JP2019521078A5 JP2018555117A JP2018555117A JP2019521078A5 JP 2019521078 A5 JP2019521078 A5 JP 2019521078A5 JP 2018555117 A JP2018555117 A JP 2018555117A JP 2018555117 A JP2018555117 A JP 2018555117A JP 2019521078 A5 JP2019521078 A5 JP 2019521078A5
Authority
JP
Japan
Prior art keywords
bacterium
compound
compound according
bacteria
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018555117A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521078A (ja
JP6964600B2 (ja
Filing date
Publication date
Priority claimed from NO20160680A external-priority patent/NO341815B1/en
Application filed filed Critical
Publication of JP2019521078A publication Critical patent/JP2019521078A/ja
Publication of JP2019521078A5 publication Critical patent/JP2019521078A5/ja
Application granted granted Critical
Publication of JP6964600B2 publication Critical patent/JP6964600B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018555117A 2016-04-22 2017-04-21 新たな抗菌化合物 Active JP6964600B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20160680A NO341815B1 (en) 2016-04-22 2016-04-22 New antimicrobial compound, a method of producing it, pharmaceutical compositions and uses in therapy
NO20160680 2016-04-22
PCT/EP2017/059521 WO2017182632A1 (en) 2016-04-22 2017-04-21 New antimicrobial compound

Publications (3)

Publication Number Publication Date
JP2019521078A JP2019521078A (ja) 2019-07-25
JP2019521078A5 true JP2019521078A5 (enExample) 2020-05-21
JP6964600B2 JP6964600B2 (ja) 2021-11-10

Family

ID=58692467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018555117A Active JP6964600B2 (ja) 2016-04-22 2017-04-21 新たな抗菌化合物

Country Status (11)

Country Link
US (1) US10494375B2 (enExample)
EP (1) EP3445766B1 (enExample)
JP (1) JP6964600B2 (enExample)
CN (1) CN109195971B (enExample)
DK (1) DK3445766T3 (enExample)
ES (1) ES2909248T3 (enExample)
HR (1) HRP20220350T1 (enExample)
NO (1) NO341815B1 (enExample)
PL (1) PL3445766T3 (enExample)
PT (1) PT3445766T (enExample)
WO (1) WO2017182632A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109280692A (zh) * 2018-10-31 2019-01-29 广东药科大学 一种蜚蠊内生放线菌的抗真菌活性筛选方法及其发酵方法
KR102112570B1 (ko) * 2019-01-28 2020-05-19 한국해양과학기술원 신규 람노리피드 화합물 및 이의 용도
CN109956951B (zh) * 2019-04-11 2021-01-01 中国医学科学院医药生物技术研究所 鹿色霉素(cervinomycin)C1、C2、C3、C4及其生产方法及应用
CN120478324A (zh) * 2025-04-28 2025-08-15 暨南大学 泛酸或其药学上可接受的盐在制备增强病原菌对达托霉素的敏感性的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494913A (en) * 1994-12-13 1996-02-27 Schering Corporation Antifungal compounds
DE102006002427A1 (de) * 2006-01-09 2007-07-12 Combinature Biopharm Ag Neue Lysolipin Derivate
WO2007095696A1 (en) * 2006-02-27 2007-08-30 The University Of Queensland Polyketide xanthones and uses thereof

Similar Documents

Publication Publication Date Title
JP2019048857A5 (enExample)
JP2018199695A5 (enExample)
JP2019521078A5 (enExample)
Liu et al. A Vibrio owensii strain as the causative agent of AHPND in cultured shrimp, Litopenaeus vannamei
Dong et al. Natural occurrence of edwardsiellosis caused by Edwardsiella ictaluri in farmed hybrid red tilapia (Oreochromis sp.) in Southeast Asia
US12478652B2 (en) Bacteriophage therapy
JP2019108378A5 (enExample)
JP2019163267A5 (enExample)
JP2019517828A5 (enExample)
JP2013542992A5 (enExample)
MA33489B1 (fr) Procédé de synthèse amélioré de la pirfénidone
CR20200584A (es) Compuestos tetrahidro-1h-pirazino [2,1-a] isoindolilquinolina para el tratamiento de enfermedades autoinmunes
HRP20220350T1 (hr) Novi antimikrobni spoj
Suanyuk et al. Mortality and pathology of hybrid catfish, C larias macrocephalus (G ünther)× C larias gariepinus (B urchell), associated with E dwardsiella ictaluri infection in s outhern T hailand
Li et al. Identification and phylogenetic analysis of Vibrio vulnificus isolated from diseased Trachinotus ovatus in cage mariculture
RU2011133824A (ru) Фармацевтическая композиция для защиты животного от растройства, возникающего в результате инфекции бактерий, которая относится к группе нокардиоформных актиномицетов
KR102470808B1 (ko) 염증성 장질환 예방 또는 치료용 조성물
Jiang et al. Isolation, identification, and biological control in vitro of tail rot pathogen strain from Hippocampus kuda
JPWO2020037271A5 (enExample)
Abouelfetouh et al. Investigation and treatment of fusidic acid resistance among methicillin-resistant staphylococcal isolates from Egypt
US20150238543A1 (en) Compositions and method for treating neutralizing microorganisms
US20230405036A1 (en) A new streptomyces spororaveus strain and a new antibiotics against bacteria and fungi
NO20081789L (no) Substituert sykloalkenderivat
JP2025534753A (ja) 健康を改善するための化合物および方法
WO2019218986A1 (zh) 鸢尾黄素在治疗鸡坏死性肠炎中的医用用途